To evaluate safety and efficacy (with regards to devices' ability to guide NGT placement) in clinical study. Chief Investigator: Kev DhaliwalNumber and location of participating sites (by region/country): N/AEudraCT number: N/AISRCTN number: N/A Funder: MRC DPFSStart and End dateOf grant award: 06 January 2022 - 30 November 2025Of recruitment: N/A Current Status: Open UK GDPR Privacy Statement: As part of Patient Information Sheet Trial website: TBC ECTU involvement: Data Management & Programming / Statistics This article was published on 2025-02-07